These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30377054)

  • 1. STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice.
    Kaltenecker D; Themanns M; Mueller KM; Spirk K; Golob-Schwarzl N; Friedbichler K; Kenner L; Haybaeck J; Moriggl R
    Cytokine; 2019 Dec; 124():154573. PubMed ID: 30377054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
    Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
    Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model.
    Hatting M; Spannbauer M; Peng J; Al Masaoudi M; Sellge G; Nevzorova YA; Gassler N; Liedtke C; Cubero FJ; Trautwein C
    Cell Death Dis; 2015 Mar; 6(3):e1667. PubMed ID: 25741592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer.
    Friedbichler K; Themanns M; Mueller KM; Schlederer M; Kornfeld JW; Terracciano LM; Kozlov AV; Haindl S; Kenner L; Kolbe T; Mueller M; Snibson KJ; Heim MH; Moriggl R
    Hepatology; 2012 Mar; 55(3):941-52. PubMed ID: 22031092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.
    Maeda S; Kamata H; Luo JL; Leffert H; Karin M
    Cell; 2005 Jul; 121(7):977-90. PubMed ID: 15989949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
    Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
    Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
    Helms TH; Mullins RD; Thomas-Ahner JM; Kulp SK; Campbell MJ; Lucas F; Schmidt N; LeMoine DM; Getaneh S; Xie Z; Phelps MA; Clinton SK; Coss CC
    Sci Rep; 2021 Feb; 11(1):3646. PubMed ID: 33574348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma.
    Mittenbühler MJ; Sprenger HG; Gruber S; Wunderlich CM; Kern L; Brüning JC; Wunderlich FT
    Mol Metab; 2018 Nov; 17():122-133. PubMed ID: 30224299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth arrest and DNA damage-inducible protein (GADD34) enhanced liver inflammation and tumorigenesis in a diethylnitrosamine (DEN)-treated murine model.
    Chen N; Nishio N; Ito S; Tanaka Y; Sun Y; Isobe K
    Cancer Immunol Immunother; 2015 Jun; 64(6):777-89. PubMed ID: 25832002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease.
    Ambade A; Satishchandran A; Gyongyosi B; Lowe P; Szabo G
    World J Gastroenterol; 2016 Apr; 22(16):4091-108. PubMed ID: 27122661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
    Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diethylnitrosamine-induced hepatocarcinogenesis is suppressed in lecithin:retinol acyltransferase-deficient mice primarily through retinoid actions immediately after carcinogen administration.
    Shirakami Y; Gottesman ME; Blaner WS
    Carcinogenesis; 2012 Feb; 33(2):268-74. PubMed ID: 22116467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription coactivator PBP/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse.
    Matsumoto K; Huang J; Viswakarma N; Bai L; Jia Y; Zhu YT; Yang G; Borensztajn J; Rao MS; Zhu YJ; Reddy JK
    Carcinogenesis; 2010 Feb; 31(2):318-25. PubMed ID: 20007298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice.
    Iwai S; Murai T; Makino S; Min W; Morimura K; Mori S; Hagihara A; Seki S; Fukushima S
    Cancer Lett; 2007 Feb; 246(1-2):115-21. PubMed ID: 16569478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of DEN-induced liver tumourigenesis in hepatocyte-specific Lass2-knockout mice coincident with upregulation of the TGF-β1-Smad4-PAI-1 axis.
    Chen L; Lu X; Zeng T; Chen Y; Chen Q; Wu W; Yan X; Cai H; Zhang Z; Shao Q; Qin W
    Oncol Rep; 2014 Feb; 31(2):885-93. PubMed ID: 24337404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
    Weber SN; Bohner A; Dapito DH; Schwabe RF; Lammert F
    PLoS One; 2016; 11(7):e0158819. PubMed ID: 27391331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice.
    Mueller KM; Kornfeld JW; Friedbichler K; Blaas L; Egger G; Esterbauer H; Hasselblatt P; Schlederer M; Haindl S; Wagner KU; Engblom D; Haemmerle G; Kratky D; Sexl V; Kenner L; Kozlov AV; Terracciano L; Zechner R; Schuetz G; Casanova E; Pospisilik JA; Heim MH; Moriggl R
    Hepatology; 2011 Oct; 54(4):1398-409. PubMed ID: 21725989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolome Analyses Uncovered a Novel Inhibitory Effect of Acyclic Retinoid on Aberrant Lipogenesis in a Mouse Diethylnitrosamine-Induced Hepatic Tumorigenesis Model.
    Qin XY; Tatsukawa H; Hitomi K; Shirakami Y; Ishibashi N; Shimizu M; Moriwaki H; Kojima S
    Cancer Prev Res (Phila); 2016 Mar; 9(3):205-14. PubMed ID: 26744170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Hepatic Transcription Factor EB Attenuates Alcohol-Associated Liver Carcinogenesis.
    Chao X; Wang S; Hlobik M; Ballabio A; Ni HM; Ding WX
    Am J Pathol; 2022 Jan; 192(1):87-103. PubMed ID: 34717896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.
    Sakurai T; Maeda S; Chang L; Karin M
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10544-51. PubMed ID: 16807293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.